Cite
Hatori Y, Sakai H, Kunishima T, et al. Rationale and design of ASSAF-K (A study of the safety and efficacy of anticoagulant therapy in the treatment of atrial fibrillation in Kanagawa). J Arrhythm. 2016;33(2):111-116doi: 10.1016/j.joa.2016.07.008.
Hatori, Y., Sakai, H., Kunishima, T., Hatori, N., Chen, L., Ishigami, T., Satoh, N. (2017). Rationale and design of ASSAF-K (A study of the safety and efficacy of anticoagulant therapy in the treatment of atrial fibrillation in Kanagawa). Journal of arrhythmia, 33(2), 111-116. https://doi.org/10.1016/j.joa.2016.07.008
Hatori, Yutaka, et al. "Rationale and design of ASSAF-K (A study of the safety and efficacy of anticoagulant therapy in the treatment of atrial fibrillation in Kanagawa)." Journal of arrhythmia vol. 33,2 (2017): 111-116. doi: https://doi.org/10.1016/j.joa.2016.07.008
Hatori Y, Sakai H, Kunishima T, Hatori N, Chen L, Ishigami T, Satoh N. Rationale and design of ASSAF-K (A study of the safety and efficacy of anticoagulant therapy in the treatment of atrial fibrillation in Kanagawa). J Arrhythm. 2017 Apr;33(2):111-116. doi: 10.1016/j.joa.2016.07.008. Epub 2016 Aug 23. PMID: 28416976; PMCID: PMC5388051.
Copy
Download .nbib